In NASH, approximately 40% of mitochondria exhibit structural abnormalities, leading to increased ROS production, resulting in lipid peroxidation of mitochondrial membranes, increased TNF-α expression, and impaired functionality (Echeverría et al., 2022). Here, TNF is linked to metabolic dysfunction-associated steatohepatitis.